Related Experiment Videos
Current evidence on the relationship between four polymorphisms in the matrix metalloproteinases (MMP) gene and
Ping Zhou1, Liang-Feng Du, Guo-Qiang Lv
1Department of Intensive Care Unite, The Third Affiliated Hospital to Nantong University, Wuxi 214041, Jiangsu, China.
Abstract:
The matrix metalloproteinases (MMP) can degrade various components of the extracellular matrix and its functional genetic polymorphisms may be associated with breast cancer risk. However, this relationship remains controversial. A meta-analysis was conducted in order to investigate the potential association between four polymorphisms in the MMP gene and breast cancer risk. A database search yielded a total of 9 studies involving 2,597 cases and 2,618 controls. Four polymorphisms were included in the meta-analysis: MMP-1 -1607 2G/1G (rs1799750), MMP-2 -1306 C/T (rs243865), MMP-3 -1171 6A/5A (rs3025058) and MMP-9 -1562 C/T (rs3918242). Crude odds ratios (OR) with 95% confidence intervals (CI) were used to assess the strength of association. When all the studies were pooled into the meta-analysis, we found that breast cancer cases had a significantly higher frequency of CC genotype (OR = 1.27, 95% CI = 1.10, 1.47; P = 0.001) and lower frequency of CT genotype (OR = 0.78, 95% CI = 0.67, 0.91; P = 0.001) of MMP-2. No significant difference was found in any genotype of MMP-1, MMP-3 or MMP-9. In conclusion, this meta-analysis suggested that MMP-2 -1306 C/T polymorphism may contribute to breast cancer susceptibility. More studies were needed especially in Asians in the future.
Insights
Genetic variations in matrix metalloproteinases (MMP) and breast cancer risk were examined. A meta-analysis found the MMP-2 -1306 C/T polymorphism is associated with increased breast cancer susceptibility.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Matrix metalloproteinases (MMPs) degrade extracellular matrix components.
- Functional genetic polymorphisms in MMPs may influence breast cancer risk.
- Previous studies on MMP polymorphisms and breast cancer risk have yielded controversial results.
Purpose of the Study:
- To investigate the association between four specific MMP gene polymorphisms and breast cancer risk.
- To clarify the controversial relationship between MMPs and breast cancer susceptibility.
Main Methods:
- A meta-analysis was performed on 9 studies with 2,597 cases and 2,618 controls.
- Four polymorphisms were analyzed: MMP-1 -1607 2G/1G (rs1799750), MMP-2 -1306 C/T (rs243865), MMP-3 -1171 6A/5A (rs3025058), and MMP-9 -1562 C/T (rs3918242).
- Crude odds ratios (OR) with 95% confidence intervals (CI) were calculated.
Main Results:
- The MMP-2 -1306 C/T polymorphism showed a significantly higher frequency of the CC genotype (OR = 1.27, 95% CI = 1.10–1.47) and a lower frequency of the CT genotype (OR = 0.78, 95% CI = 0.67–0.91) in breast cancer cases.
- No significant associations were found for any genotypes of MMP-1, MMP-3, or MMP-9.
Conclusions:
- The MMP-2 -1306 C/T polymorphism may contribute to breast cancer susceptibility.
- Further research, particularly in Asian populations, is warranted to confirm these findings.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
The Tumor Microenvironment